UDI medical devices GCC

GCC 2026 Regulatory Trends Shaping Pharma and Biotech

Leave a Comment / Uncategorized / 7fiza0177@gmail.com

GCC pharma regulations in 2026 emphasize eCTD v4.0 adoption, harmonization, real-world evidence, and strict Saudi/UAE rules. Strategic compliance and local QPPV roles are key for market access.

GCC 2026 Regulatory Trends Shaping Pharma and Biotech Read More »

Regulatory Affairs in the Middle East: A Comprehensive Guide for Pharma, Biotech, and MedTech

Leave a Comment / Uncategorized / 7fiza0177@gmail.com

Guide details regulatory pathways for pharma, biotech, and MedTech in KSA, UAE, and Egypt, highlighting PharmaOasis Germans EG’s centralized support for registration, compliance, and market access.

Regulatory Affairs in the Middle East: A Comprehensive Guide for Pharma, Biotech, and MedTech Read More »